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THE APPROACH TO CARCINOMA OF THE PROXIMAL HEPATIC DUCTS:
MORE RADICAL OR MORE CONSERVATIVE
ABSTRACT
S. Bengmark, H Ekberg, A. Evander, B. Klofver-Stahl and K-G. Tranberg (1988)
Major liver resection for hilar cholangiocarcinoma. Ann. Surg. 207;120-125.
Between 1968 and 1984 liver resection with curative attempt was performed in 22 patients with hilar
cholangiocarcinoma. Right lobectomy was performed in 4 patients, extended right lobectomy in 7,
left lobectomy in 8, and excision of the median segment of the left lobe (segment IV) in 3. Bilio-
enteric continuity was restored by hepatocholedochostomy in 17 patients and hepatojejunostomy in
4. (One patient had external transhepatic catheter drainage and no internal bile drainage).
Operative mortality rate was 27% and caused by excessive intraoperative bleeding, sepsis, or liver
insufficiency. Postoperative complications occurred in 57% of patients surviving the operation and
were due mainly to leakage from the hepatocholedochostomy. Median survival was 6 months, and
one third of the patients survived I year. Three patients survived 10 years and were among the four
patients in whom a tumor-free resection margin was obtained (one ofthem died in the postoperative
phase). It is concluded that resection of hilar cholangiocarcinoma may give long-term survival if a
free resection margin is obtained. The importance of a free resection margin indicates that surgery
should be aggressive and include liver resection.254 HPB INTERNATIONAL
ABSTRACT
Terblanche J. Kahn D, Bornman PC, and Werner D. The role of U-tube palliative
treatment in high bile duct carcinoma. Surgery 1988;103;624-632.
Twenty-one patients with cholangiocarcinoma at the confluence of the main right and left hepatic
ducts were referred to our professorial surgical unit between 1968 and 1982. All were evaluated,
treated, and documented prospectively with follow-up to mid 1986. No lesion was deemed
resectable. The U-tube palliative bypass developed during the course of the study was used in 14
patients, and its role in treating high bile duct carcinoma was evaluated. Histologic confirmation of
the diagnosis was obtained in 71% of patients. Seven patients received additional treatment with
radical radiotherapy. The 30-day overall hospital mortality rate was 19%. The 1- and 2-year
survival rates were 57% and 33% respectively. The quality of survival was usually good. The need
for centralized referral and treatment ofthese difficult patients is stressed. The case against radical
resection for this lesion is presented. It is concluded that radical resection is seldom possible, and
therefore the U-tube palliative procedure is advocated in most patients.
PAPER DISCUSSION
Carcinoma of the proximal extrahepatic bile ducts is an uncommon disease, but has
elicited considerable interest and controversy because ofour inability thus far to treat it
satisfactorily in most patients. These tumours characteristically present with
obstruction at the bile duct bifurcation. If the site of origin has been more proximal in
the right or left hepatic ducts, considerable local involvement of liver or blood vessels
may occur before the tumour becomes symptomatic. Even small tumours discovered
early may have associated tumour growing along perineural lymphatics at a distance
from the primary. As a result, most attempts at local surgical resection are
unsuccessful. This has led some groups to develop more extensive radical surgical
approaches to this tumour, and others to abandon surgery as the main therapeutic
modality. The papers of Bengmark and Terblanche are good examples of these two
approaches from two highly respected centers with considerable experience in biliary
surgery.
The Lund group has taken the radical surgical approach and reports 22 patients in
whom resection of bifurcation cancer along with liver resection was carried out. The
authors have taken the position that attempts at radical excision of hilar carcinoma
must include liver resection because ofthe tendency oflocal spread, and the need to get
clear margins to effect a cure. The achievement of three longterm survivors out of 22
resected patients is impressive. There is however, clearly a price that has been paid by
this approach, namely a 27% operative mortality and 57% complication rate in
operative survivors, as well as a median survival of only approximately seven months.
One wonders if this price is worth a 10% five year survival. Also the authors do not
indicate how selective they have been in choosing patients for such radical surgery. For
example to find 22 patients suitable for resection, how many patients with proximal
biliary carcinoma were assessed?Howmany were explored? What was done with those
patients not radically resected? The answers to these questions are required before one
can put this radical surgical approach into perspective. This group has howeverHPB INTERNATIONAL 255
demonstrated that a cure of these proximal tumours is possible with radical surgery
alone. The challenge from this point on would be to develop the operative approach to
the point where the operative mortality and morbidity can be reduced substantially so
that the years of life gained in the few cures are not negated by opportunities for
palliation lost due to operative complications and deaths. Iwasaki has reported two
five year survivors in ten patients undergoing radical resection ofbifurcation tumours,
most including liver, without any operative deaths. Lygidakis2 has reported an even
more radical approach for patients with vascular involvement, which includes vascular
resection and reconstruction. Eleven ofthirteen patients survived resection but none of
these survived long term. These two reports of very aggressive surgical treatment with
low mortality provide encouragement to study further this radical surgical approach.
The Cape Town group takes the opposite view point, namely that these lesions are
rarely resectable for cure and reports 21 patients seen over 14 years which were treated
primarily with operative tumour dilatation and U-tube insertion. External radiation
was used in one half of those in which the tube was inserted. The early post-treatment
mortality rate was 19%, and the median survival overall was just over one year. Three
patients survived beyond five years, however in two longterm survivors, the diagnosis
ofcancer was not proven histologically. Ofnote, there was no difference in the survival
rates between patients treated by the U-tube and those without, making it difficult to
accept the recommendation that the U-tube is the preferred method of treatment.
Because of the selection of good risk patients for radiation therapy, its value was not
possible to assess from this report. This method of treatment is considerably easier to
perform than resection and the authors note that since their first report, their referral in
numbers has declined. This may be the result of patients being treated primarily by
intubation elsewhere without consideration being given to the option of resection.
Our own experience3 with proximal biliary cancer suggests that resection of the
tumour including liver resection when required, can be carried out with low mortality.
We have previously reported resecting 12 of 54 hilar tumours seen between 1969 and
1984. Adjuvant external beam radiation therapy was used in 9 and median survival in
this group of patients is now 22 months. Three of these patients have survived five
years. Operative mortality of resection ofproximal tumours in our study was 8% and
median survival of patients not resected was 6 months.
Our current approach is therefore to resect patients where possible. It is our belief
and that ofothers that this is the most likely method oftreatment to result in long term
survival or cure. The mortality associated with combined liver resection suggests that
this should be carried out only when necessary to remove all gross tumour.
In assessing other methods oftreatment regarding palliation or longterm survival, it
has been our experience that operative bypass provides better palliation, in that the
incidence of cholangitis is much less than the transhepatic tubes- either transhepatic
single tubes or U-tubes as described by Dr. Terblanche. We have not however
documented any difference in survival time between operative bypass and intubation.
Treatment techniques both surgical and radiological are still evolving in this disease.
It is important that these patients be seen in centers which have the expertise both
radiological and surgical, to provide whatever therapy might be indicated from
palliative to potentially curative. It is also important that treatment modalities be
evaluated prospectively through controlled trials. Because of the infrequency with256 HPB INTERNATIONAL
which these tumours are seen, it will be necessary to carry out multi-centered
randomized trials to assess the relative indications and roles of radical surgical
resection versus conservative management by bypass or intubation, as well as the role
of radiation, chemotherapy and the possible role of liver transplantation.
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